Patent for Semaglutide, the active ingredient in Ozempic and Wegovy expired in India on March 20

NVO's key patent on semaglutide, the active ingredient in Ozempic and Wegovy expired in India on March 20 and cheaper copies are already in market for ~14 dollars. The patent will soon expire in China and amny other countries as well.